Issues related to prescription drug pricing and value Prescription drug manufacturing and supply chains Issues related to 340B program Issues related to tax and tariffs Issues related to Intellectual Property Issues related to Inflation Reduction Act
2026 · 1st Quarter (Jan 1 - Mar 31)
BOEHRINGER INGELHEIM USA CORPORATION
Filed by BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 20, 2026
- Income
- Not reported
- Expenses
- $1,165,000.00
- Registrant
- BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
- Filing UUID
- d523c11b-9dad-4594-b3db-befdf95607c4
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025; H.R. 946/S. 1862, the Optimizing Research Progress Hope and New (ORPHAN) Cures Act Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act Issues related to Most Favored Nation Proposals Education about cancer and Medicare screening coverage, including H.R. 842/S. 339, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Literal federal measure citations: H.R. 1492, S.832, H.R. 946, S. 1862, H.R. 842, S. 339
Issues related to Animal Health Issues related to One Health Issues Related to PAW Act (H.R. 1842) Far, Food and National Security Act of 2024 (H.R. 8467) Issues related to the regulatory process Issues related to transboundary animal disease control and prevention Issues related to avian influenza Issues related to New World Screwworm Issues Related to Tax and Trade
Issues related to FY2026 Appropriations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.